Astaxanthin | YesPress

Browse all tags

ceo2915 saas2462 ai1738 fintech1461 founder1254 b2b1081 b2b saas905 san francisco823 co-founder817 san-francisco799 y combinator772 startup736 machine learning668 enterprise software637 stanford603 series a597 venture capital577 biotech543 cybersecurity537 ai agents480 healthtech479 new york startup474 enterprise-software448 generative ai438 digital health434 agentic ai404 silicon-valley389 d2c386 ecommerce381 silicon valley381 machine-learning373 startup founder361 california351 entrepreneur350 new york347 edtech345 venture-capital340 climate tech328 newsletter321 mit302 proptech302 robotics294 y-combinator282 san francisco startup278 enterprise ai277 series b274 developer tools266 computer vision255 oncology252 open-source248 series-a244 harvard242 supply chain242 sustainability240 iot232 enterprise229 compliance226 biotechnology224 workflow automation224 founder ceo218 telehealth217 developer-tools213 healthcare213 insurtech213 blockchain212 devops209 medical devices207 series-b206 logistics200 forbes 30 under 30196 llm193 uc berkeley189 author188 generative-ai188 clean energy187 deep tech187 web3186 a16z184 cloud184 drug discovery183 no-code183 crm179 b2c177 life sciences176 artificial intelligence175 manufacturing174 payments170 general partner169 healthcare ai169 serial entrepreneur168 seed funding164 open source163 automation161 podcast160 digital transformation159 hardware159 unicorn159 marketplace154 predictive analytics152 infrastructure151

Often tagged with

orn almarsson1 axelyf1 rna therapeutics1 lipid nanoparticles1 lnp delivery1 mrna1 moderna1 spikevax1 gene editing1 drug delivery1 biotech founder1 iceland biotech1 anti-inflammatory1 autoimmune1

Tagged: astaxanthin

1 result

Sort

Founder · Scientist · Executive

Örn Almarsson

Örn Almarsson is the co-founder and CEO of Axelyf, an Icelandic-American biotech building next-generation lipid nanoparticles to deliver RNA medicines beyond the liver. Before Axelyf he ran the delivery sciences team at Moderna from 2013 to 2020, helping engineer the components behind the Spikevax COVID-19 vaccine, after earlier stints at Merck and Alkermes. A bioorganic chemist by training, he is the co-author of more than 70 publications and over 60 patents, and is now pairing a proprietary lipid library with a machine-learning model called ANNA to crack the hardest problem in RNA medicine: delivery.

orn almarsson · axelyfRead →